Nap Pharma Private Limited
About Nap Pharma Private Limited
Data last updated:
Nap Pharma Private Limited is a private limited company based in Bhubaneswar, Odisha, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 22 April 2010 and has been in existence for over 16 years.
The company is registered with the Registrar of Companies (ROC), Cuttack, under CIN U24232OR2010PTC011885. Its GSTIN is 21AADCN4783H1ZI (Odisha).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹8.36 Lakh. It is led by directors Nilay Kumar Ghosh (Managing Director) and Sujit Kumar Das.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at G – 27 Ganesh Nagar Gandamunda Khandagiri, Bhubaneswar, Odisha, India – 751010.
As per the financials filed for FY 2025, the company reported a revenue of ₹99.79 Lakh. For the same year it recorded a net profit of ₹1.42 Lakh (net margin 1.4%) and EBITDA of ₹2.92 Lakh (EBITDA margin 2.9%). Revenue has grown at a compounded annual rate (CAGR) of 21% over three years and 10% over five years.
As per MCA filings, the company has open charges of ₹5 Lakh on record.
The current compliance status is marked as compliant by the Registrar of Companies.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressG – 27 Ganesh Nagar Gandamunda Khandagiri, Bhubaneswar, Odisha, India – 751010
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Nap Pharma Private Limited
The main business activity of Nap Pharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Nap Pharma Private Limited FY 2025 filings available
Nap Pharma Private Limited reported revenue of ₹99.79 Lakh for FY 2025.
Compounded Annual Growth Rate (CAGR) of Nap Pharma Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 10% over five years. EBITDA rose 12% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Nap Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹2.92 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹1.42 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Nap Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 2.9% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 1.4% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Nap Pharma are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Nap Pharma Private Limited
Nap Pharma Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Formulations). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Sanify Pharmacare Private Limited | ₹1 Cr (FY 2025) | •••• | •••• | 30.0% | •••• | Indore, Madhya Pradesh, India |
| Glowide Pharmaceuticals Private Limited | ₹1 Cr (FY 2019) | •••• | •••• | 89.0% | •••• | Nagpur, Maharashtra, India |
| Lative Life Science Private Limited | ₹1 Cr (FY 2025) | •••• | •••• | -26.0% | •••• | Ahmedabad, Gujarat, India |
| Sevarat Healthcare and Nursing Private Limited | ₹99.99 Lakh (FY 2023) | •••• | •••• | -5.0% | •••• | Bardez, Goa, India |
| Benmed Laboratories Pvt Ltd | ₹99.8 Lakh (FY 2024) | •••• | •••• | -12.0% | •••• | Kolkata, West Bengal, India |
| Nap Pharma Private Limited this company | ₹99.79 Lakh (FY 2025) | •••• | •••• | •••• | Bhubaneswar, Odisha, India | |
| Ceptor Lifesciences Private Limited | ₹99.78 Lakh (FY 2025) | •••• | •••• | 7.0% | •••• | Naigaon East, Maharashtra, India |
| Oxalis Pharmaceuticals Private Limited | ₹99.58 Lakh (FY 2024) | •••• | •••• | 43.0% | •••• | Kolhapur, Maharashtra, India |
| Gravel Pharma Private Limited | ₹99.57 Lakh (FY 2025) | •••• | •••• | 4.0% | •••• | Latur, Maharashtra, India |
| Adstrum Laboratories Private Limited | ₹99.41 Lakh (FY 2024) | •••• | •••• | 1603349.0% | •••• | Vadodara, Gujarat, India |
| Imhotef Pharmaceuticals Private Limited | ₹99.4 Lakh (FY 2025) | •••• | •••• | 14.0% | •••• | Chennai, Tamil Nadu, India |
Peers are the five companies nearest above and the five nearest below Nap Pharma by revenue in the Pharma industry (Formulations), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Nap Pharma Private Limited
Nap Pharma Private Limited is audited by HARICHANDAN KARAN & ASSOCIATES for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| HARICHANDAN KARAN & ASSOCIATES | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Nap Pharma Private Limited
Nap Pharma has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sujit Kumar Das Also directs: Nodysis Pharma Private Limited | Director | 22 Apr 2010 | 16 Years 5 Months | Current |
| Nilay Kumar Ghosh Also directs: Nodysis Pharma Private Limited | Managing Director | 22 Apr 2010 | 16 Years 5 Months | Current |
Ownership and Shareholding of Nap Pharma Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Nap Pharma Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 23 Mar 2022 | Others | ₹5 Lakh | Open |
Total charge records: 1 View all charges
Employees and EPFO Compliance at Nap Pharma Private Limited
Employment history and EPFO contributions of people linked to Nap Pharma.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Nap Pharma Private Limited
Nap Pharma Private Limited has 2 board changes on record since 2010: 2 appointments. The latest: Nilay Kumar Ghosh was appointed as Managing Director on 22 Apr 2010.
Credit Ratings, Litigation & Regulatory Alerts for Nap Pharma Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Nap Pharma Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Nap Pharma Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Nap Pharma Private Limited
Nap Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 21AADCN4783H1ZI | Odisha | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Nap Pharma Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Nap Pharma Private Limited
Nap Pharma is an active private limited company based in Bhubaneswar, Odisha, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 22 April 2010 (16+ years old) and is registered under CIN U24232OR2010PTC011885.
Nap Pharma reported revenue of ₹99.79 Lakh for FY 2025.
Nap Pharma has 2 current directors:
- Nilay Kumar Ghosh - Managing Director
- Sujit Kumar Das - Director
Nap Pharma reported a net profit of ₹1.42 Lakh (net margin 1.4%) and EBITDA of ₹2.92 Lakh (EBITDA margin 2.9%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Nap Pharma is 21% over three years and 10% over five years. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Nap Pharma is 21AADCN4783H1ZI, registered in Odisha.
The CIN (Corporate Identification Number) of Nap Pharma is U24232OR2010PTC011885. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Nap Pharma was incorporated on 22 April 2010, making it 16+ years old. It is registered with the Registrar of Companies, Cuttack.
The peers of Nap Pharma by revenue are Sanify Pharmacare Private Limited, Glowide Pharmaceuticals Private Limited, Lative Life Science Private Limited, Sevarat Healthcare and Nursing Private Limited, Benmed Laboratories Pvt Ltd and 5 more, all in the Pharma industry (Formulations).
Nilay Kumar Ghosh was appointed as Managing Director on 22 Apr 2010. Sujit Kumar Das was appointed as Director on 22 Apr 2010.
The registered office of Nap Pharma is at G – 27 Ganesh Nagar Gandamunda Khandagiri, Bhubaneswar, Odisha, India – 751010.